iCAD Partners with Microsoft to Expand AI Breast Cancer Detection Tools

iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, has formed a strategic partnership with Microsoft to integrate its advanced mammography solutions into Microsoft's Precision Imaging Network. This collaboration aims to significantly expand access to cutting-edge breast cancer detection tools for clinicians across the healthcare ecosystem.

The partnership leverages Microsoft's extensive cloud infrastructure and established radiology platforms to deliver iCAD's AI mammography tools more seamlessly into existing clinical workflows. iCAD's ProFound AI® Breast Health Suite will be fully hosted on Microsoft's network, providing radiologists and healthcare providers with streamlined access to AI-driven tools designed to enhance breast health detection, improve clinical efficiency, and ultimately aim to improve patient outcomes.

Microsoft's Precision Imaging Network serves as a gateway for healthcare providers, offering streamlined access to a curated collection of third-party AI models through a single point of integration. This network connects over 17,000 healthcare facilities across the nation. By embedding iCAD's capabilities for cancer detection and density assessment within this extensive network, the collaboration makes these advanced AI tools readily available to a vast number of radiologists and specialty physicians in diverse healthcare settings.

A key component of the partnership involves the integration with Microsoft's widely used PowerScribe platform, which a majority of U.S. radiologists rely on for AI-based reporting and workflow features. As a mammography solution offered via the Precision Imaging Network, iCAD's ProFound AI suite will be uniquely optimized for integration within PowerScribe. This allows radiologists to efficiently create, review, and share diagnostic reports by leveraging features that standardize language and automate routine reporting tasks.

"We are excited to partner with Microsoft to expand access to our AI solutions for breast cancer detection across a broader network of healthcare providers," said Dana Brown, CEO and President of iCAD. "This collaboration supports our growth strategy by expanding the reach of our industry-leading technology, driving deeper market penetration, and advancing our transition to a SaaS model. Integrating ProFound AI results in the PowerScribe report aligns with our shared mission to improve cancer detection and care while empowering radiologists to deliver earlier, more accurate interpretations with greater confidence and efficiency."

The integration aims to deliver targeted, patient-specific insights with enhanced efficiency while supporting iCAD's transition to a Software-as-a-Service (SaaS) business model.

Click here for the original news story.